Why JSPL Fell 15% in Last Three Days
Shares in Jindal Steel and power (JSPL) fell as much as 8 per cent on Friday to Rs 236.65. The stock has now corrected nearly 15 per cent in last three trading sessions compared to a 5.5 per cent loss in BSE's Metal index during the same period.
Analysts attribute the slide in JSPL's shares to the following three reasons:
1) Disappointing Q4:
JSPL's net profit slumped 28 per cent year-on-year to Rs 402.5 crore in Q4. JSPL registered 16 per cent degrowth in the steel volume and 1 per cent dip in its power volumes.
Mr Ravi Uppal, managing director and CEO of JSPL said profits fell due to higher depreciation and interest cost. There was also a planned shutdown at the Raigarh plant which weighed on JSPL's profit, he said.
2) Capex Raise:
JSPL raised its fiscal 2015 capital expenditure guidance by 65-100 per cent to Rs 5,000-6,000 crore as compared to earlier projection of Rs 3,000 crore. This means JSPL will have to raise fresh debt, which will translate to a higher debt/equity ratio for next four to six quarters.
Analysts say it will be a tough task for JSPL to service the increased debt given the fact that interest rates are at three year high and sales volume has been sluggish.
3) Orissa ore issue:
JSPL is largely dependent on iron ore supplies from Sarda mines in Orissa, whose environmental clearance expired in March 2014. The Orissa government has directed production from the mines to be stopped. Production from these mines will be stopped if the Supreme Court bans iron ore mining in Orissa.
JSPL says that it has inventories for 6-7 months from its mines in Raigarh.
Shares in JSPL closed 6.36 per cent lower at Rs 239 compared to a flat close in Nifty.
-
Getting To Work Costs Women More | The Reason Why
It is not just about women paying more than men. It is about women paying much more in cities than in villages.
-
AI Bias In Investing Cannot Be Eliminated, But It Can Be Governed
Framing is a particularly important example as identical financial information presented in terms of gains rather than losses can lead an LLM to reach a different assessment.
-
Joining The Dots | Dark Skies, Steady Diya: Why Hope Holds This Diwali
With war, a weak rupee and foreign outflows weighing on sentiment, policymakers at the NDTV World Summit and market veterans at NDTV Profit Ignite: Diwali Edition offered the same advice: stay invested and filter out the noise.
-
The Curious Case of Equitas Small Finance Bank And A CEO Who Quit For Stock
PN Vasudevan believes persistent investor concerns over a perceived conflict of interest had become a governance overhang on Equitas Small Finance Bank's stock, even as the lender improved profitability and asset quality.
-
Talking Points This Week: AI Cash Burn, A Tiger Comeback And An India That Still Finds Its Own Path
India is not immune to higher oil or tighter global liquidity, yet its earnings base is broader, its domestic policy levers are still available.
-
Foreign Investors Own Half Of HDFC Bank and ICICI Bank. An LTCG Cut Could Matter Most Here
Foreign portfolio investors have US$115 billion parked in HDFC Bank, ICICI Bank. If the government cuts long-term capital gains tax, Jefferies says returning foreign money could land here first.
-
'Never Seen This Level Of Negativity': Sandeep Tandon Says The Next Rally May Be Closer Than You Think
Veteran investor Sandeep Tandon says foreign selling is easing, large-caps are due a comeback and mid-caps are crowded, while he turns positive on gold, power and pharma this Diwali.
-
Indians Stay With Family, Not In Hotels | The Reason Why
India still lacks enough clean, reliable and affordable hotels for budget-conscious travellers.
-
The Economic Imperative: Analysing The Material Driving Force Behind India-Canada Strategic Reset
This economic complementarity is further reinforced by deep institutional investment ties and talent mobility, which form the bedrock of the bilateral framework.
-
Medicine Pricing: Where Must Profit Stop?
India must confront excessive margins, hidden incentives and regulatory gaps that threaten the integrity of medicine.